Expression of e-cadherin and β-catenin in human esophageal squamous cell carcinoma: relationships with prognosis

Table 1 Relationships between espression of E-cadherin and β-catenin an clinicopathological parameters in patients with ESCC

Group	Total	E-cadherin			P	β-catenin			P
		+	±	-	rs	+	±	-	rs
Histologic grade
I	17	8	8	1		9	6	2
II	69	25	33	11	0.001	21	28	20	0.014
III	20	3	7	10	-0.309	2	12	6	-0.238
Tumor size (cm)
< 3.0	10	6	2	2		0	5	5
3.0-5.0	41	16	18	7		15	15	11
5.0-7.0	44	11	24	9	0.054	12	24	8	0.213
≤ 7.0	11	3	4	4	-0.187	5	2	4	-0.212
Clinical staging
I	2	2	0	0		0	2	0
IIa	31	16	11	4		13	13	5
IIb	10	2	5	3	0.013	3	2	5	0.124
III	60	15	31	14	-0.241	6	27	17	-0.150
IV	3	1	111	1		0	2	1
Venous invasion
Yes	27	5	14	8	0.042	6	12	9	0.237
No	79	31	34	14	-0.198	26	34	19	-0.116
Lymph nodemetastasis
Yes	47	11	22	14	0.014	13	21	13	0.646
No	59	25	26	8	-0.239	19	25	15	-0.045